News

CytoDyn Announces FDA Clearance of Its Phase II Oncology Trial

VANCOUVER, Washington, Nov. 04, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing…

3 weeks ago

CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium

BERKELEY HEIGHTS, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and…

3 weeks ago

Vireo Growth Inc. Announces New $10 Million Convertible Debt Facility

MINNEAPOLIS, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), a cannabis…

3 weeks ago

Allogene Therapeutics Announces Participation in November Investor Conferences

SOUTH SAN FRANCISCO, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering…

3 weeks ago

111, Inc. Announces Change to Board of Directors

SHANGHAI, Nov. 4, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company…

3 weeks ago

United Imaging Healthcare Announces Q3 2024 Results with Revenue of January to September of 6.95 Billion CNY

SHANGHAI, Nov. 4, 2024 /PRNewswire/ -- United Imaging Healthcare (SSE: 688271), a global leader in manufacturing advanced medical imaging and…

3 weeks ago

Måna Care Delivers Innovative Age Tech Digital Assistant to Enhance Elderly In-Home Care

STALLARHOLMEN, Sweden, Nov. 4, 2024 /PRNewswire/ -- Måna Care AB is pleased to announce a new strategic partnership with the Foundation…

3 weeks ago

Relief Therapeutics Signs Non-Binding Letter of Intent with Renexxion for Reverse Merger

GENEVA, SWITZERLAND / ACCESSWIRE / November 4, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical…

3 weeks ago

NanoViricides to Provide Corporate Update at the Spartan Capital Investors Conference 2024, Today at 9:45am

SHELTON, CT / ACCESSWIRE / November 4, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader…

3 weeks ago

Pioneering Scientist David Deamer to receive ABRF Award for Outstanding Contributions to Biomolecular Technologies

 LEXINGTON, Ky. , Nov. 2, 2024 /PRNewswire/ -- The Association of Biomolecular Resource Facilities (ABRF) is pleased to announce the selection…

3 weeks ago